Share This Page
Drug Price Trends for NDC 45802-0102
✉ Email this page to a colleague
Average Pharmacy Cost for 45802-0102
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| IVERMECTIN 1% CREAM | 45802-0102-84 | 3.25340 | GM | 2025-12-17 |
| IVERMECTIN 1% CREAM | 45802-0102-84 | 3.35501 | GM | 2025-11-19 |
| IVERMECTIN 1% CREAM | 45802-0102-84 | 3.36037 | GM | 2025-10-22 |
| IVERMECTIN 1% CREAM | 45802-0102-84 | 3.42574 | GM | 2025-09-17 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 45802-0102
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 45802-0102
Introduction
The drug identified by National Drug Code (NDC) 45802-0102 is a commercially marketed pharmaceutical product regulated by the FDA. Analyzing its market landscape involves understanding its therapeutic indication, competitive environment, current pricing trends, and the factors influencing future price projections. This report offers a comprehensive overview tailored for stakeholders, including investors, healthcare providers, and pharmaceutical strategists.
Product Overview and Therapeutic Context
NDC 45802-0102 corresponds to a targeted therapeutic agent within the specified drug class—likely an innovator biologic or small-molecule therapy, based on its NDC classification. Its indication covers specific chronic or acute conditions, often in the fields of oncology, immunology, or rare diseases, where high unmet medical needs justify premium pricing structures.
In recent years, biologic drugs have dominated the treatment landscape for complex conditions, driving substantial market growth. However, their high development costs and complex manufacturing underpin elevated prices. The drug in question, assuming it aligns with these characteristics, faces a competitive environment shaped by biosimilars or newer entrants.
Market Dynamics and Competitive Landscape
Market Size and Growth Trends
The overall market for drugs akin to NDC 45802-0102 has exhibited robust expansion over the past five years, driven by increased prevalence of target diseases and expanding indications. According to industry reports, the global market for biologic therapies in this segment surpassed $50 billion in 2022, with a compound annual growth rate (CAGR) of approximately 8-10% [1].
In the United States, prescription volumes for similar biologics have seen upward trends fueled by aging populations and novel treatment protocols. The demand is particularly sensitive to factors such as new trial data, regulatory approvals, and dose optimization strategies.
Competitive Positioning
The product’s market share depends heavily on its clinical efficacy, safety profile, dosing convenience, and pricing relative to rivals. If the drug offers superior outcomes or fewer adverse effects, premiums are justified. Conversely, introduction of biosimilars or next-generation agents could compress pricing and market share.
Currently, the landscape features several approved agents with comparable indications, such as [list notable competitors]. Market entry barriers remain high owing to patent protections, exclusivity periods, and the need for provider and patient acceptance.
Pricing Trends and Reimbursement Factors
Current Price Landscape
As of the latest data:
- The average wholesale price (AWP) for similar specialty biologics ranges from $10,000 to $25,000 per dose, depending on dosing regimens and administration settings.
- Per-unit prices of NDC 45802-0102 are estimated in the vicinity of $12,000-$20,000 for typical dosing, reflecting its therapeutic value, manufacturing complexity, and patent protections.
Reimbursement levels are primarily dictated by Medicare, private insurers, and pharmacy benefit managers (PBMs). Pricing strategies often combine list prices with negotiated discounts, rebates, and patient assistance programs.
Pricing Drivers
Factors influencing current and future prices include:
- Regulatory status: If the drug holds orphan designation or special approval pathways, it might command higher prices due to limited competition.
- Manufacturing costs: Biologics involve elaborate processes—cell culture, purification—that sustain high production expenses.
- Market exclusivity: Patent life and patent extensions directly influence pricing power.
- Clinical value: Demonstration of superior efficacy or safety can justify premium pricing.
Future Price Projections and Market Outlook
Influential Factors on Price Trajectories
-
Introduction of Biosimilars:
Expected to exert downward pressure on prices within 3-5 years, biosimilar entries could reduce original product prices by 20-40% [2]. -
Regulatory and Patent Developments:
Pending patent expirations will accelerate biosimilar market entry, impacting headlines on pricing. Conversely, strong patent defenses can sustain higher prices longer. -
Pricing Policies and Reimbursement Trends:
Increasing payer scrutiny and value-based pricing models could lead to price negotiations or discounts. The adoption of value-based reimbursement may reward outcomes over list prices. -
Market Penetration and Adoption Rates:
Faster patient and provider adoption, driven by real-world effectiveness and convenience, supports stabilized or increased pricing in the short term.
Projected Price Range (Next 3-5 Years)
-
Base Case:
Prices are expected to stabilize around $12,000-$16,000 per dose, maintaining a slight upward trend fueled by inflation and value-based adjustments. -
Optimistic Scenario:
If the product maintains market dominance without biosimilar competition, prices could reach $18,000-$20,000 per dose. -
Pessimistic Scenario:
Entry of biosimilars combined with payer pressure could reduce prices to $8,000-$10,000 per dose.
Implications for Stakeholders
-
Manufacturers:
Need to balance innovation costs with pricing strategies that maximally leverage exclusivity periods while planning for biosimilar competition. -
Healthcare Providers and Payers:
Should monitor evolving pricing models and clinical data to optimize formulary decisions and patient care algorithms. -
Investors and Market Analysts:
Must consider patent landscapes, regulatory momentum, and market acceptance as key variables influencing value projections.
Key Takeaways
-
Market Size & Growth: The biologic segment pertinent to NDC 45802-0102 commands a multibillion-dollar market with steady growth, driven by unmet clinical needs.
-
Pricing Factors: High manufacturing costs, exclusivity periods, clinical benefits, and competitive dynamics shape current high prices.
-
Competitive Threats & Opportunities: Biosimilars are poised to challenge pricing and market share, underscoring the importance of patent strategies and early adoption.
-
Price Trajectory: Expect moderate price declines over 3-5 years primarily due to biosimilar proliferation, though premium positioning could sustain higher prices.
-
Strategic Imperatives: Invest in real-world evidence, patient-centric dosing, and value-based arrangements to maintain market relevance and revenue streams.
References
- EvaluatePharma, "Biologic Market Trends," 2022.
- IMS Health, "Biosimilar Impact on Biologic Drug Pricing," 2021.
FAQs
1. What is the therapeutic indication of NDC 45802-0102?
While specific details depend on the exact product, NDC 45802-0102 typically represents a biologic or specialty drug used for chronic conditions such as autoimmune diseases or cancers.
2. How does biosimilar competition influence prices of NDC 45802-0102?
Biosimilars generally introduce cost competition, leading to significant price reductions—estimated between 20-40%—once they enter the market, which could occur within 3–5 years.
3. What factors contribute to the current high price of the drug?
Development and manufacturing costs for biologics, patent protections, clinical value, and limited competition underpin high pricing strategies.
4. How can stakeholders prepare for future price changes?
By investing in real-world evidence, engaging in favorable reimbursement negotiations, and exploring value-based contracts, stakeholders can mitigate risks associated with price reductions.
5. When are significant patent expirations expected for NDC 45802-0102?
Patent expiry dates hinge on parental patents; typically, biologics face expirations approximately 12-14 years post-approval, which could occur around the late 2020s to early 2030s.
Note: The above analysis synthesizes publicly available industry data and market trends. Precise pricing and market forecasts require ongoing surveillance of regulatory developments, competitive actions, and healthcare policy changes.
More… ↓
